-
Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed)
(PA-19-237)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
The first application due date for this FOA is June 16, 2019.
-
Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30 - Clinical Trial Not Allowed)
(PAR-19-232)
National Institute of General Medical Sciences
Application Receipt Date(s): October 8, 2019; October 8, 2020; October 8, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project (U01 Clinical Trial Not Allowed)
(PAR-19-234)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Reducing the Duration of Untreated Psychosis in the United States (R34 Clinical Trial Required)
(PAR-19-235)
National Institute of Mental Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Reducing the Duration of Untreated Psychosis in the United States (R01 Clinical Trial Required)
(PAR-19-236)
National Institute of Mental Health
Application Receipt Date(s): Standard dates apply,, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Short-term Mentored Career Enhancement Award in Dental, Oral and Craniofacial Research for Mid-Career and Senior Investigators (K18 Independent Clinical Trial Not Allowed)
(PAR-19-238)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Clinical Research to Improve the Oral Health of Older Adults (R01 Clinical Trial Not Allowed)
(PAR-19-239)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
The first standard application due date for this FOA isOctober 5, 2019.
-
Clinical Research to Improve the Oral Health of Older Adults (R21 Clinical Trial Not Allowed)
(PAR-19-240)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
The first standard application due date for this FOA is October 1?6, 2019.
-
Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Trial Optional)
(PAS-19-241)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Targeted Prevention for Tickborne Diseases (R01 Clinical Trial Not Allowed)
(RFA-AI-19-037)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): August 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: CNS Data Generation (UM1 Clinical Trial Not Allowed)
(RFA-DA-19-037)
National Institute on Drug Abuse
Application Receipt Date(s): May 8, 2019 and October 8, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
No late applications will be accepted for this Funding Opportunity Announcement
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed)
(RFA-DA-19-038)
National Institute on Drug Abuse
Application Receipt Date(s): May 8, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed)
(RFA-DA-19-039)
National Institute on Drug Abuse
Application Receipt Date(s): May 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Limited Competition for Adolescent Brain Cognitive Development (ABCD) Study - Linked Research Project Sites (Collaborative U01 Clinical Trial Not Allowed)
(RFA-DA-20-002)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
Office of Behavioral and Social Sciences Research
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): July 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Limited Competition for Adolescent Brain Cognitive Development (ABCD) Study - Data Analysis, Informatics and Resource Center (U24 Clinical Trial Not Allowed)
(RFA-DA-20-003)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
Office of Behavioral and Social Sciences Research
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): July 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Limited Competition for Adolescent Brain Cognitive Development (ABCD) Study - Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-DA-20-004)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
Office of Behavioral and Social Sciences Research
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): July 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Revolutionizing Innovative, Visionary Environmental health Research (RIVER) (R35 Clinical Trial Not Allowed)
(RFA-ES-19-007)
National Institute of Environmental Health Sciences
Application Receipt Date(s): June 20, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Revolutionizing Innovative, Visionary Environmental health Research (RIVER) (R35 Basic Experimental Studies with Humans Required)
(RFA-ES-19-008)
National Institute of Environmental Health Sciences
Application Receipt Date(s): June 20, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Conduct Studies to Establish More Targeted Durations of Use for Certain Approved Antimicrobial New Animal Drugs in Food Animals (U01 Clinical Trial Required)
(RFA-FD-19-024)
Food and Drug Administration
Application Receipt Date(s): June 3, 2019, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
Rare Disease Cohorts in Heart, Lung, Blood and Sleep Disorders (UG3/UH3 Clinical Trial Not Allowed)
(RFA-HL-20-014)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): June 18, 2019, June 17, 2020 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Accelerating Medicine Partnership in Parkinsons disease (AMP PD) unbiased proteomics biofluid analysis (U01 Clinical Trials Not Allowed)
(RFA-NS-19-028)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): May 29, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
(RFA-RM-19-005)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): September 9, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
(RFA-RM-19-006)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): August 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.